Enzymatic Wound Debridement Market Trends, Segmentation and Future Scope

The global Enzymatic Wound Debridement Market size is expected to reach USD 1.10 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 5.8% CAGR during the forecast period Introduction of technologically advanced products and rise in incidence of chronic diseases are some of the key factors aiding growth.

Various initiatives are being undertaken by researchers and key players are developing technologically advanced products owing to rising demand for enzymatic wound debridement products globally, which is anticipated to boost market growth. Until now, collagenase-based enzymatic wound debridement products have been majorly used for treatment of chronic & acute wounds and papain-based products have been predominantly used for treatment of chronic wounds. Since awareness about the use of such products is increasing, several technologically advanced products are being introduced in the market. For instance, NexoBrid (NXB), previously referred to as Debriding Gel Dressing (DGD)—which is derived from pineapple Bromelain group of enzymes-was introduced in 2017. NXB is an enzymatic wound debriding drug that can be effectively used in treating deep burn wounds.

The product recently received approval and market players are undertaking initiatives to launch this product under their wound care product portfolio. For instance, in May 2019, Vericel Corporation entered into a supply agreement and exclusive license with MediWound Ltd. with an aim to commercialize the product in North America. The product also received approval in European Union, the U.S., and other international markets. Therefore, such initiatives are anticipated to positively impact growth over the forecast period.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/enzymatic-wound-debridement-market

Further key findings from the report suggest:

• In terms of revenue, acute wounds segment held the largest share in 2018 owing to rising trauma cases
• Homecare segment is expected to witness fastest growth rate over the forecast period owing to increasing geriatric population suffering from chronic wounds, who prefer homecare over hospital stay
• Collagenase product segment held the largest share in 2018 due to rising incidence of chronic wounds
• Asia Pacific is expected to witness fastest growth over the forecast period owing to rising number diabetic patients in this region
• Some prominent players operating in enzymatic wound debridement market are Smith & Nephew, Mölnlycke Health Care, ConvaTec, and B. Braun.

 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com